The invention relates to application of compounds having a general structural formula:where R= Li, Na, K,R1= -H, -NH2, -Cl, -OH, -COOH,B = -CH=, Z = -CH=,A = -CH=and/or their pharmacologically acceptable salts as an active ingredient having appropriate activity with respect to nitrergic and/or dopaminergic systems, in a pharmaceutical composition having a directed action to important mediator systems of an organism, in particular, for treatment of various diseases associated with nitrergic and dopaminergic systems of an organism. Such diseases include neurologic, neuropsychic and cardiovascular diseases.
